We are pleased to announce the Cold Spring Harbor Asia conference on Iron, Reactive Oxygen Species & Ferroptosis in Life, Death & Disease will be held in Awaji, Japan, located approximately 60 km west of Osaka city.

The conference will begin in the evening of Sunday November 15, 2026, and will conclude after the banquet in the evening of November 19, 2026. The conference will include eight oral sessions and one poster session covering the latest findings across many topics in iron, ROS & ferroptosis biology. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Posters will be up for viewing and discussion throughout the conference. Social events throughout the conference provide ample opportunity for informal interactions. 

Conference Venue & Accommodation
Cold Spring Harbor Asia conferences in JAPAN are arranged in Awaji Yumebutai International Conference Center (https://www.yumebutai.co.jp/lang/en.html), which is part of a one-of-a-kind “environment creation” project equipped with professional conference facilities and blended into the magnificent landscape, designed by the famous architect Tadao Ando. Meeting participants are strongly recommended to stay at the conference hotel, Grand Nikko Awaji (https://awaji.grandnikko.com/en/) during the meeting with the rest of the participants if possible. The accommondation booking URL will be sent to you after completion of meeting registration.

Major Topics:

1. Emerging methods for detecting Fe(II), Fe(III), H2O2, superoxide, lipid peroxides and ferroptosis in cells, tissues and whole organisms

2. The use of iron, ROS and ferroptosis as biomarkers

3. Signaling and molecular regulation of iron, ROS, and ferroptosis

4. Links between metabolism, ferroptosis, iron and ROS

5. The development of chemical probes and drugs that modulate iron, ROS, and ferroptosis

6. Novel transgenic mouse and cell models for key players of the ferroptotic process

7. The role of iron, ROS and ferroptosis in diverse pathologies, and targeting iron, ROS and ferroptosis for disease treatment

Invited Speakers: 

José Pedro Friedmann Angeli, University of Würzburg

Kivanç Birsoy, The Rockefeller University

Quan Chen, Nankai University

Marcus Conrad, Helmholtz Zentrum München

Gina DeNicola, Moffitt Cancer Center

Scott Dixon, Stanford University

Tasuku Hirayama, Gifu Pharmaceutical University

Ying Hu, Harbin Institute of Technology

Kazuhiro Iwai, Kyoto University

Xuejun Jiang, Memorial Sloan Kettering Cancer Center

Silvia von Karstedt, University of Cologne

Namgyu Lee, Dankook University

Tak Mak, University of Toronto

Hozumi Motohashi, Tohoku University

James Olzmann, University of California, Berkeley

Raphael Rodriguez, Institut Curie

Philipp Scherer, UT Southwestern Medical Center

Shiori Sekine, University of Pittsburgh

Brent Stockwell, Columbia University

Shinya Toyokuni, Nagoya University

Jessalyn Ubellacker, Harvard School of Public Health

Jiao Wu, Fourth Military Medical University

Ken-ichi Yamada, Kyushu University

Qing Zhong, Shanghai Jiao Tong University

Yilong Zou, Westlake University

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers. 

Fellowship: 
We are eager to have as many young people as possible to attend our international meetings since they are likely to benefit most from meeting other international colleagues in the same field. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards after the meeting to off set the registration fee. Announcements of the awardees will be made during the Banquet of the meeting.

We look forward to seeing you at Awaji, Japan in November, 2026.